Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Loxo Oncology
Loxo Oncology
Bayer steps up with $1.55B deal to take a lead role in commercializing Loxo’s cancer drugs
Endpoints
Tue, 11/14/17 - 07:59 am
Bayer
Loxo Oncology
cancer
gene therapy
Loxo Oncology's Up 230% in the Past Year -- Can You Still Make Money Buying It?
Motley Fool
Sun, 09/17/17 - 09:53 am
Loxo Oncology
larotrectinib
Loxo beefs up its genetics-based cancer drug pipeline with an unusual $40M deal
Endpoints
Mon, 07/31/17 - 10:08 am
Loxo Oncology
LOXO-305
Loxo Oncology Shares Rally, Despite Diluting Investors
Motley Fool
Thu, 06/15/17 - 09:41 am
Loxo Oncology
larotrectinib
Precision Oncology Drug Shows Power Of Cancer Genomics
Forbes
Fri, 06/9/17 - 09:59 am
cancer genomics
Loxo Oncology
LOXO-101
ASCO 2017
A New Cancer Drug Helped Almost Everyone Who Took It. Almost. Here's What It Teaches Us
Forbes
Sun, 06/4/17 - 11:40 am
cancer
oncology
larotrectinib
Loxo Oncology
clinical trials
patients
Loxo takes center stage at ASCO with its groundbreaking shot at a biomarker-based cancer drug approval
Endpoints
Sat, 06/3/17 - 09:21 am
Loxo Oncology
ASCO 2017
biomarkers
LOXO-101
larotrectinib
We're on the verge of seeing cancer in a drastically different light
Yahoo/Business Insider
Mon, 04/18/16 - 10:13 am
cancer
Loxo Oncology
LOXO-101
clinical trials
Loxo lands $24M venture round and a CSO for cancer drug research
Fierce Biotech
Wed, 05/7/14 - 08:24 am
Loxo Oncology
CSO
R&D
cancer
Pages
« first
‹ previous
1
2
3